IL10 and lung carcinoma: To evaluate the effect of combining an EGFR inhibitor with an anti-IL10 antibody on lung cancer formation, EGFRL858R mice that had developed lung tumors were administered gefitinib and the anti-IL10 antibody by intraperitoneal injection (Figure 4E).